Treating people with type 2 diabetes.
As the symposium of articles in this issue shows, there are now many options for managing type 2 diabetes. Potent new oral or injectable hypoglycaemic medications can be added to older drugs or used alone. In addition to metformin, the British National Formulary (Joint Formulary Committee, 2013) lists five sulfonylureas, two meglitinides, four dipeptidyl peptidase-4 inhibitors, two glucagon-like peptide-1 agonists, an inhibitor of intestinal alpha glucosidases, a sodium-glucose co-transporter 2 inhibitor, and a thiazolidinedione. Their various formulations form a list of 30 drugs in MIMS (www.mims.co.uk/).